AMINDA KIM: Open Payments
NPI 1780232280 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 9 payments from 6 companies in 2025. Trend: 2023 $229 · 2024 $845 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $218 |
| MERZ NORTH AMERICA, INC. | 2 | $180 |
| Amgen Inc. | 1 | $146 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| REVANCE THERAPEUTICS, INC. | 1 | $54 |
| ABBVIE INC. | 2 | $41 |
Products named: BREZTRI, Ozempic, DAXXIFY, BOTOX, Xeomin.
Industry payments across TN — which companies pay providers there.
